MannKind Corp
NASDAQ:MNKD
MannKind Corp
NASDAQ:MNKD
Price:
2.5
USD
-1.57%
Market Closed
Market Cap:
$770.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MannKind Corp
NASDAQ:MNKD
|
US |
|
Allgeier SE
LSE:0RUM
|
DE |
|
H
|
Hantop Inc
KOSDAQ:002680
|
KR |
|
WLM Participacoes e Comercio de Maquinas e Veiculos SA
BOVESPA:WLMM4
|
BR |
|
Lanthanein Resources Ltd
ASX:LNR
|
AU |
|
P
|
Pearson PLC
F:PES
|
UK |
|
N
|
New Hope Service Holdings Ltd
HKEX:3658
|
CN |
|
Tata Coffee Ltd
NSE:TATACOFFEE
|
IN |
|
Paysign Inc
NASDAQ:PAYS
|
US |
|
Heung-A Shipping Co Ltd
KRX:003280
|
KR |
|
R
|
Rotem Shani Entrepreneurship and Investments Ltd
TASE:RTSN
|
IL |
|
Nsx Ltd
ASX:NSX
|
AU |
|
H.U. Group Holdings Inc
TSE:4544
|
JP |
|
Chung Hung Steel Corp
TWSE:2014
|
TW |
|
Mepet Metro Petrol ve Tesisleri Sanayi Ticaret AS
IST:MEPET.E
|
TR |
|
Capital Ltd
F:C8D
|
UK |
|
C
|
CammSys Corp
KOSDAQ:050110
|
KR |
|
Admiral Group PLC
LSE:ADM
|
UK |
|
Osisko Gold Royalties Ltd
TSX:OR
|
CA |
|
GLP J-REIT
TSE:3281
|
JP |
|
Autins Group PLC
LSE:AUTG
|
UK |
Multiples-Based Value
The
Multiples-Based Value for
MannKind Corp (MNKD)
under the Base Case is
hidden
USD.
Compared with the current market price of 2.5 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MNKD Multiples-Based Value
LOCKED
Multiples Across Competitors
MNKD Competitors Multiples
MannKind Corp Competitors
MannKind Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
MannKind Corp
NASDAQ:MNKD
|
769.6m USD | 2.2 | 131.3 | 17.1 | 20.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
